The stock market is a collection of markets and exchanges where activities related to the buying, selling, and issuance of shares of publicly traded companies occur. It serves as a platform for investors to trade equity securities (stocks) and provides companies with access to capital in exchange for giving investors a slice of ownership in the company. The stock market is primarily divided into the primary market, where new issues of stocks are sold through initial public offerings (IPOs), and the secondary market, where existing shares are traded among investors. Prices in the stock market are determined by supply and demand dynamics, influenced by various factors such as economic indicators, corporate performance, and investor sentiment. The stock market plays a crucial role in the global economy by facilitating capital accumulation and providing liquidity to investors, allowing them to enter and exit positions in companies easily.
Marker Therapeutics is highly rated by Canaccord Genuity for its innovative cancer cell therapies, aiming for an target price from . Krystal Biotech garners a strong buy from Jefferies, targeting…
Recursion Pharmaceuticals experiences a 23.88% increase in stock value, reflecting its innovative approach in the biotech landscape. The company leverages automation and AI through its proprietary operating system to discover…
Legend Biotech is poised for a significant stock surge, with projections indicating a potential 129% increase by 2025. The company has achieved impressive growth, notably a year-over-year increase in net…
Biotech Innovator Targets Obesity Treatments Metsera, a biotech startup based in New York, is poised to make a significant entrance into the public markets with its upcoming IPO. The company…
**Oncolytics Biotech Inc. (TSE:ONC)** has been making headlines after its shares surged past the significant threshold of its two hundred-day moving average. During Friday's trading session, the stock peaked at…
A Strong Buy Signal for Investors Recently, Puma Biotech (PBYI) received a significant boost, achieving a Zacks Rank #1, indicating a **Strong Buy** rating. This upgrade is a result of…
Kane Biotech's Stellar Q3 Performance Kane Biotech has announced its impressive financial results for the third quarter of 2024, highlighted by the celebrated commercial launch of their revyve™ Wound Gel.…